112237 ⎘
Vectors comprising a targeting moiety Vectors comprising as targeting moiety peptide derived from defined protein
Sub-classes:ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
#2S. PYOGENES CAS9 MUTANT GENES AND POLYPEPTIDES ENCODED BY SAME
#3Cas9 mutant genes and polypeptides encoded by same
#4ORTHOGONAL TRANSCRIPTIONAL SWITCHES DERIVED FROM TET REPRESSOR HOMOLOGS FOR SACCHAROMYCES CEREVISIAE
#5Cleavable fusion tag for protein overexpression and purification
#6Cas9 mutant genes and polypeptides encoded by same
#7Cleavable fusion tag for protein overexpression and purification
#8Methods and compositions for treating genetic eye diseases
#9Synthetic transcriptional and epigenetic regulators based on engineered, orthogonal zinc finger proteins
#10Targeting of herpes simplex virus to specific receptors
#11ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION
#12Vault and vault like carrier molecules
#13Gene delivery system and method of use
#14POLYPEPTIDE-NUCLEIC ACID CONJUGATES AND USES THEREOF
#15METHODS AND COMPOSITIONS RELATED TO PHAGE-NANOPARTICLE ASSEMBLIES
#16SCLEROPROTEIN OF AN ADENO-ASSOCIATED VIRUS WITH MODIFIED CHROMATOGRAPHIC PROPERTIES, THE PRODUCTION THEREOF AND USE OF THE SAME
#17Vault and vault-like carrier molecules
#18Methods of treating lysosomal storage related diseases by gene therapy
#19METHODS FOR TARGETING MODIFIED RAAV VECTORS TO MAMMALIAN CELLS
#20SCLEROPROTEIN OF AN ADENO-ASSOCIATED VIRUS WITH MODIFIED CHROMATOGRAPHIC PROPERTIES, THE PRODUCTION THEREOF AND USE OF THE SAME
#21METHODS AND COMPOSITIONS FOR ADENO-ASSOCIATED VIRUS (AAV) WITH HI LOOP MUTATIONS
#22rAAV EXPRESSION SYSTEMS AND COMPOSITIONS
#23rAAV Expression Systems and Methods of Use
#24VIRAL VECTOR-BASED GENE THERAPY METHODS AND COMPOSITIONS
#25Targeting of herpes simplex virus to specific receptors
#26SCLEROPROTEIN OF AN ADENO ASSOCIATED VIRUS WITH MODIFIED CHROMATOGRAPHIC PROPERTIES, THE PRODUCTION THEREOF AND USE OF THE SAME
#27TRANSGENIC ORGANISM
#28Scleroprotein of an adeno-associated virus with modified chromatographic properties, the production thereof and use of the same
#29Targeting of genetic vaccine vectors
#30Lipid carrier and method of preparing the same
#31Capsid-modified adenovirus vectors and methods of using the same
#32Compositions and methods for targeting or imaging a tissue in a vertebrate subject
#33Efficient generation of adenovirus-based libraries by positive selection of adenoviral recombinants through ectopic expression of the adenovirus protease
#34Circular expression construct for gene therapeutic applications
#35Vault and vault-like carrier molecules
#36Method of using adenoviral vectors with increased persistence in vivo
#37Non-invasive gene targeting to ocular cells
#38DNA/RNA transduction technology and its clinical and basic applications
#39Vp2-modified raav vector compositions and uses therefor
#40Raav expression systems for genetic modification of specific capsid proteins
#41Targeting of herpes simplex virus to specific receptors
#42Methods of treating lysosomal storage related diseases by gene therapy
#43Modular transport systems for molecular substances and production and use thereof
#44Targeting of genetic vaccine vectors
#45Non-viral linear DNA vectors and methods for using the same
#46Compositions and methods for tissue specific targeting of lentivirus vectors
#47Pseudotyped lentiviral vectors and uses thereof
#48Gene delivery system and methods of use